Recent Finacing
Recent Raise
Abalos Therapeutics develops arenavirus‑based oncolytic immunotherapies using a proprietary Fast Evolution platform to generate tumor‑targeting viral variants, advancing lead candidates into Phase 1/2 trials for solid tumors.
